Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 646 shares at $500.00 ($323K) on 2024-08-30, disclosed to the SEC on 2024-09-04.
Scheduled sale ($323k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-08-12 | $1.2M | — | Filing → |